Volume 5, Issue 5 (October 1999)

Meeting Report

First Gordon Research Conference on Neurovirology and Second International NeuroVirology Symposium 1999 Colby-Sawyer College, New Hampshire, USA
[No authors listed]
pp. 437-44


The problems of latent varicella zoster virus in human ganglia: precise cell location and viral content
Mahalingam R, Kennedy PG, Gilden DH.
pp. 445-8


Transgenic expression of interleukin-6 in the central nervous system confers protection against acute herpes simplex virus type-1 infection
Carr DJ, Campbell IL.
pp. 449-57

Effects of Selegiline in a retroviral rat model for neurodegenerative disease
Czub M, Czub S, Gosztonyi G, Koutsilieri E, Sopper S, Muller JG, Gerlach M, Riederer P, ter Meulen V.
pp. 458-64

Tumor necrosis factor-alpha and virus expression in the central nervous system of cats infected with feline immunodeficiency virus
Poli A, Pistello M, Carli MA, Abramo F, Mancuso G, Nicoletti E, Bendinelli M.
pp. 465-73

Spread of bovine herpesvirus type 5 (BHV-5) in the rabbit brain after intranasal inoculation
Lee BJ, Weiss ML, Mosier D, Chowdhury SI.
pp. 474-84

Basis of rabies virus neurovirulence in mice: expression of major histocompatibility complex class I and class II mRNAs
Irwin DJ, Wunner WH, Ertl HC, Jackson AC.
pp. 485-94

Absence of evidence of Borna disease virus infection in Swedish patients with Chronic Fatigue Syndrome
Evengard B, Briese T, Lindh G, Lee S, Lipkin WI.
pp. 495-9

Measuring HIV-1 RNA and interferon-alpha in the cerebrospinal fluid of AIDS patients: insights into the pathogenesis of AIDS Dementia Complex
Krivine A, Force G, Servan J, Cabee A, Rozenberg F, Dighiero L, Marguet F, Lebon P.
pp. 500-6

Neurotoxicity of CSF from HIV-infected humans
Meeker RB, Robertson K, Barry T, Hall C.
pp. 507-18

Soluble HIV-1 infected macrophage secretory products mediate blockade of long-term potentiation: a mechanism for cognitive dysfunction in HIV-1-associated dementia
Xiong H, Zeng YC, Zheng J, Thylin M, Gendelman HE.
pp. 519-28

Short Communication

A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients
Ongradi J, Rajda C, Marodi CL, Csiszar A, Vecsei L.
pp. 529-32